{"id":"https://openalex.org/W2910691263","doi":"https://doi.org/10.1182/blood-2018-99-115564","title":"Activation of NF-Kappa B-p62-NRF2 Signaling Supports the Survival of CLL Cells That Express High Levels of ROR1","display_name":"Activation of NF-Kappa B-p62-NRF2 Signaling Supports the Survival of CLL Cells That Express High Levels of ROR1","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2910691263","doi":"https://doi.org/10.1182/blood-2018-99-115564","mag":"2910691263"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-115564","doi":"https://doi.org/10.1182/blood-2018-99-115564","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-115564","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010869502","display_name":"Elsa S\u00e1nchez\u2010L\u00f3pez","orcid":"https://orcid.org/0000-0002-4236-1985","observed_orcids":["https://orcid.org/0000-0002-4236-1985"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Elsa Sanchez-Lopez","raw_affiliation_strings":["School of Medicine. Departments of Pharmacology and Pathology., University of California San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine. Departments of Pharmacology and Pathology., University of California San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081515833","display_name":"Emanuela M. Ghia","orcid":"https://orcid.org/0000-0002-6060-6106","observed_orcids":["https://orcid.org/0000-0002-6060-6106"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emanuela M. Ghia","raw_affiliation_strings":["Moores Cancer Center, University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores Cancer Center, University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101404975","display_name":"Laura Antonucci","orcid":"https://orcid.org/0000-0002-3659-7334","observed_orcids":["https://orcid.org/0000-0002-3659-7334"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Laura Antonucci","raw_affiliation_strings":["School of Medicine. Departments of Pharmacology and Pathology., University of California San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine. Departments of Pharmacology and Pathology., University of California San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010336471","display_name":"Laura Z. Rassenti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Z. Rassenti","raw_affiliation_strings":["Moores Cancer Center, University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores Cancer Center, University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100416568","display_name":"Yun Chen","orcid":"https://orcid.org/0000-0003-0973-9170","observed_orcids":["https://orcid.org/0000-0003-0973-9170","https://orcid.org/0009-0002-5557-4995"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yun Chen","raw_affiliation_strings":["Moores Cancer Center, University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores Cancer Center, University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["Moores Cancer Center, University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores Cancer Center, University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056315342","display_name":"Michael Karin","orcid":"https://orcid.org/0000-0002-2758-6473","observed_orcids":["https://orcid.org/0000-0002-2758-6473"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael Karin","raw_affiliation_strings":["School of Medicine. Departments of Pharmacology and Pathology., University of California San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine. Departments of Pharmacology and Pathology., University of California San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5010869502","https://openalex.org/A5056315342","https://openalex.org/A5100416568","https://openalex.org/A5101404975"],"corresponding_institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"3122","last_page":"3122"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9639999866485596},{"id":"https://openalex.org/keywords/ror1","display_name":"ROR1","score":0.9589999914169312},{"id":"https://openalex.org/keywords/p62","display_name":"p62","score":0.9819999933242798},{"id":"https://openalex.org/keywords/nrf2-signaling-pathway","display_name":"Nrf2 signaling","score":0.8930000066757202},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.9039999842643738},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.8309999704360962},{"id":"https://openalex.org/keywords/cll-cell-survival","display_name":"CLL cell survival","score":0.5640000104904175},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.6909999847412109},{"id":"https://openalex.org/keywords/nqo1","display_name":"NQO1","score":0.8259999752044678},{"id":"https://openalex.org/keywords/gpx2","display_name":"GPX2","score":0.8330000042915344},{"id":"https://openalex.org/keywords/gstm1","display_name":"GSTM1","score":0.7839999794960022},{"id":"https://openalex.org/keywords/sod1","display_name":"SOD1","score":0.9290000200271606},{"id":"https://openalex.org/keywords/mdm2","display_name":"MDM2","score":0.9919999837875366},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6890000104904175},{"id":"https://openalex.org/keywords/oxidative-stress-response","display_name":"oxidative stress response","score":0.3630000054836273}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.606197714805603},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5072683691978455},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.5037559866905212},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.49761226773262024},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.48457372188568115},{"id":"https://openalex.org/C123298856","wikidata":"https://www.wikidata.org/wiki/Q15317427","display_name":"NFKB1","level":4,"score":0.46305346488952637},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3488645553588867},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.18674853444099426},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.15662622451782227},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-115564","doi":"https://doi.org/10.1182/blood-2018-99-115564","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-115564","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3003816116","https://openalex.org/W2588593462","https://openalex.org/W4405034621","https://openalex.org/W2575920423","https://openalex.org/W2528277149","https://openalex.org/W2559634437","https://openalex.org/W2532476953","https://openalex.org/W2979329021","https://openalex.org/W2536952211","https://openalex.org/W4409636814"],"abstract_inverted_index":{"Abstract":[0],"Recent":[1],"studies":[2,121],"have":[3],"linked":[4],"the":[5,39,186,289,300,335,353,420,469,504,517],"autophagy":[6],"adaptor":[7],"p62/SQSTM1":[8],"to":[9,32,89,172,195,199,205,387,495,555,592],"tumorigenesis":[10],"via":[11],"NRF2":[12,242,390,424],"signaling.":[13],"Increased":[14],"accumulation":[15,46,91,187,222,232,505,564],"p62":[16,224,231],"is":[17,47,78,103,450],"associated":[18,104],"with":[19,105,212,283,296,343,361,412,432,455,550],"disease":[20,588],"progression":[21,589],"in":[22,28,95,101,138,182,191,319,378,407,429,452,468,473,525,560,594],"many":[23],"cancers,":[24],"however":[25],"its":[26],"expression":[27,43,99,133,179,215,240,265,284,298,457],"CLL":[29,59,63,102,139,149,183,210,227,277,281,321,341,359,430,453,475,479,483,595],"has":[30],"yet":[31],"be":[33],"investigated.":[34],"Importantly,":[35],"p62,":[36,189],"encoded":[37],"by":[38,49,235,514,545],"SQSTM1":[40,309,368],"gene,":[41],"mRNA":[42,239,435],"and":[44,108,131,166,203,238,253,258,294,313,349,372,440,460,481,498,563,578,590],"protein":[45,75,237,489],"regulated":[48],"nuclear":[50,156],"factor-kappa":[51],"B":[52,596],"(NF-\u03baB),":[53],"a":[54,466,533,575],"key":[55],"transcription":[56],"factor":[57,157,160],"for":[58],"survival.":[60],"In":[61,323,417],"addition,":[62,324],"cells":[64,82,150,211,228,282,342,360,431,454,480,597],"express":[65,487,599],"receptor":[66,70],"tyrosine":[67],"kinase-like":[68],"orphan":[69],"1":[71],"(ROR1),":[72],"an":[73,616,638,651,664,676,693],"oncoembryonic":[74],"that":[76,123,169,177,209,308,423,447,462,486,598],"also":[77],"expressed":[79,403],"on":[80,615,637,650,663,675,692],"cancer":[81],"of":[83,92,125,134,155,180,188,197,216,223,241,275,286,337,346,355,364,438,458,491,506,516,523,565,570,602,619,641,654,667,679,696],"numerous":[84],"malignancies,":[85,97],"including":[86,244],"those":[87],"reported":[88],"show":[90],"p62.":[93],"As":[94],"solid-tumor":[96],"high-level":[98,178,213],"ROR1":[100,181,217,287,297,347,365,434,459],"enhanced":[106,236,470],"disease-progression":[107],"shorter":[109],"overall":[110],"survival":[111,202],"(Cui":[112],"B,":[113],"et":[114,142,270,395],"al,":[115,143,396],"Blood":[116],"25:2931,":[117],"2016).":[118],"Furthermore,":[119,548],"recent":[120],"found":[122,208],"activation":[124,130,154,196],"Wnt5a-ROR1":[126],"cascade":[127,449,585],"induces":[128,503],"NF-\u03baB":[129,135],"increased":[132,152],"target":[136],"genes":[137,392,426],"(Chen,":[140],"Y":[141],"submitted":[144],"ASH":[145],"Abstract,":[146],"2018).":[147],"Additionally,":[148],"exhibit":[151],"basal":[153],"erythroid":[158],"2-related":[159],"2":[161],"(NRF2),":[162],"which":[163,190,511,539,583],"supports":[164],"antioxidant":[165,519],"detoxifying":[167],"responses":[168],"enhance":[170,200,587],"resistance":[171,204,554,591],"cytotoxic":[173],"drugs.":[174],"We":[175,207,261,279,306,380],"hypothesized":[176],"may":[184,464,586],"influence":[185],"turn":[192],"could":[193],"lead":[194],"NRF2-signaling":[198],"CLL-cell":[201],"therapy.":[206],"surface":[214],"(ROR1HIGH)":[218],"had":[219,340,358],"significantly":[220,317,376],"greater":[221],"than":[225],"ROR1LOW":[226,257],"(p=0.003).":[229],"Elevated":[230],"was":[233,530],"accompanied":[234],"targets,":[243],"NQO1":[245,311,370,492,524,546],"(p=0.009),":[246,369],"GPX2":[247],"(p=0.019),":[248],"GSTM1":[249],"(p=0.001),":[250],"SOD1":[251],"(p=0.001)":[252,255],"MDM2":[254],"(n=6":[256],"n=13":[259],"ROR1HIGH).":[260],"analyzed":[262],"published":[263],"gene":[264,382],"data":[266,445],"(GSE13204,":[267],"Kohlmann":[268],"A,":[269],"al":[271],"BJH":[272],"142:802,":[273],"2008),":[274],"448":[276],"cases.":[278],"designated":[280,536],"levels":[285,345,363,406,601],"above":[288],"medium":[290,301],"(n=224)":[291],"as":[292,303,537],"ROR1HI":[293,320,408],"cases":[295],"below":[299],"value":[302],"ROR1LO":[304,413],"(n=224),":[305],"confirmed":[307,531],"(p=0.01),":[310],"(p=0.0001)":[312],"HMOX1":[314,373],"(p=0.002)":[315],"were":[316,375,402,427,493],"overexpressed":[318,377],"patients.":[322],"we":[325],"segregated":[326],"GSE13204":[327],"dataset":[328],"into":[329],"two":[330],"groups:":[331],"ROR1>90%":[332,410],"(n=45),":[333,351],"representing":[334,352],"10%":[336,354],"patients":[338,356],"who":[339,357],"highest":[344],"mRNA,":[348],"ROR1<10%":[350,415],"lowest":[362],"mRNA.":[366],"Consistently,":[367],"(p=0.02)":[371],"(p=0.008)":[374],"ROR1>90%.":[379],"performed":[381],"set":[383],"enrichment":[384],"analysis":[385],"(GSEA)":[386],"investigate":[388],"whether":[389],"inducible":[391,425],"(Malhotra":[393],"D,":[394],"Nucleic":[397],"Acids":[398],"Research":[399,609,624,631,646,687],"38(17):5718,":[400],"2010)":[401],"at":[404],"higher":[405],"or":[409,414,621,643,656,669,681,698],"compared":[411],"CLL.":[416],"both":[418],"comparisons,":[419],"GSEA":[421],"revealed":[422],"enriched":[428],"high":[433,456,488,600],"(FDR":[436],"q":[437],"0.01":[439],"0.06,":[441],"respectively).":[442,500],"Collectively,":[443],"these":[444],"indicate":[446],"p62-NRF2":[448],"upregulated":[451],"suggest":[461],"it":[463],"play":[465],"role":[467,522],"proliferation":[471],"observed":[472],"ROR1HIGH":[474,478],"cells.":[476],"Similarly,":[477],"MEC1-ROR1":[482],"cell":[484,528],"line":[485],"level":[490],"resistant":[494],"ABT-199":[496,556],"(p<0.05":[497],"p<0.001":[499],"Such":[501],"agent":[502],"reactive":[507],"oxygen":[508],"species":[509],"(ROS),":[510],"are":[512],"detoxified":[513],"products":[515],"NRF2-activated":[518],"response.":[520],"The":[521],"protection":[526],"from":[527],"death":[529],"using":[532],"specific":[534],"pro-drug,":[535],"29h,":[538],"becomes":[540],"active":[541],"after":[542],"being":[543],"metabolized":[544],"(p<0.05).":[547],"treatment":[549],"29h":[551],"overcame":[552],"NQO1-mediated":[553],"(venetoclax)":[557],"(p<0.05),":[558],"resulting":[559],"PARP":[561],"cleavage":[562],"cytoplasmic":[566],"cytochrome":[567],"C,":[568],"markers":[569],"apoptosis.":[571],"This":[572],"study":[573],"illustrates":[574],"previously":[576],"unknown":[577],"intricate":[579],"signaling":[580],"network":[581],"through":[582],"ROR1-NF-\u03baB-p62-NRF2":[584],"therapy":[593],"ROR1.":[603],"Disclosures":[604],"Kipps:":[605],"Genentech":[606],"Inc:":[607],"Consultancy,":[608,612,630,634,685],"Funding;":[610,625,632,647,688],"AbbVie:":[611],"Honoraria,":[613,635,673,686,690],"Membership":[614,636,649,662,674,691],"entity's":[617,639,652,665,677,694],"Board":[618,640,653,666,678,695],"Directors":[620,642,655,668,680,697],"advisory":[622,644,657,670,682,699],"committees,":[623,645],"F.":[626],"Hoffmann-La":[627],"Roche":[628],"Ltd:":[629],"Pharmacyclics:":[633],"Verastem:":[648,661],"committees;":[658,671,683],"Celgene:":[659],"Consultancy;":[660],"Janssen:":[672,689],"Gilead:":[684],"committees.":[700]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-01-25T00:00:00"}